GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ultimovacs ASA (FRA:7UM) » Definitions » Net Policyholder Benefits/Claims

Ultimovacs ASA (FRA:7UM) Net Policyholder Benefits/Claims


View and export this data going back to 2019. Start your Free Trial

What is Ultimovacs ASA Net Policyholder Benefits/Claims?

Net Policyholder Benefits/Claims only applies to insurance companies.


Ultimovacs ASA (FRA:7UM) Business Description

Industry
Traded in Other Exchanges
Address
Ullernchausseen 64, Oslo, NOR, 0379
Ultimovacs ASA is a pharmaceutical company involved in developing novel immunotherapies against cancer. Its product candidate is UV1, a peptide-based vaccine inducing T cell responses against the universal cancer antigen telomerase. The company and its proprietary technology are based on preclinical and clinical research on immunotherapies conducted at the Oslo University Hospital.